Notes
National Health Service
Reference
NICE. Patients with high-risk skin cancer have new treatment option. Internet Document : 17 Sep 2018. Available from: URL: https://www.nice.org.uk/news/article/patients-with-high-risk-skin-cancer-have-new-treatment-option
Rights and permissions
About this article
Cite this article
NICE recommends dabrafenib plus trametinib for melanoma. PharmacoEcon Outcomes News 812, 39 (2018). https://doi.org/10.1007/s40274-018-5306-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5306-3